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Abstract 1 
 2 
Purpose: This study explored the in vitro anti-oxidant and anti-platelet activities of 3 
hydroxytyrosol, hydroxytyrosol acetate, 3,4-dihydroxyphenylglycol, and two phenolic 4 
olive extracts. These compounds and extracts were obtained from a new industrial 5 
process to treated hydrothermally the alperujo (160 ºC/60 min), a by-product of olive oil 6 
extraction.  7 
Methods: The extracts and the purified compounds have been obtained 8 
chromatographically using both ionic and adsorbent resins. The antioxidant activity has 9 
been determined by measuring inhibition of human platelet aggregation and inhibition 10 
of lipid peroxidation in liver microsomes of vitamin-E deficient rats.  11 
Results: The positive effect of the extracts on the inhibition of platelets 12 
aggregation is showed, being higher in the case of hydroxytyrosol acetate and by the 13 
first time, its synergist effect with hydroxytyrosol has been proved. The phenolic extract 14 
and the isolated phenols showed good results for inhibiting the lipid oxidation, mainly 15 
the hydroxytyrosol acetate. A synergistic effect occurred when the hydroxytyrosol 16 
acetate and the 3,4-dihydroxyphenylglycol were supplemented by hydroxytyrosol.  17 
Conclusion: These results suggest these extract and compounds obtaining from a 18 
novel industrial process could be natural alternatives for the prevention of diseases 19 
related with cardiovascular disorder or oxidative damages.  20 
 21 
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1. Introduction 26 
 27 
Consumption of the Mediterranean diet, characterized by high consumption of 28 
olive oil, fruits, vegetables, grains and legumes, reduces the incidence of major 29 
cardiovascular events [1] and is associated with a lower risk of peripheral artery disease 30 
[2]. The health benefits of the Mediterranean diet have been attributed to high 31 
concentration of free radical-scavenging polyphenols such as flavonoids. Virgin olive 32 
oil is rich in unsaponifiable minor components such as sterols, tocopherols, and 33 
polyphenols. The polyphenols are natural antioxidants that not only contribute to the 34 
stability of the oil, but also have anti-inflammatory and anti-atherosclerotic properties 35 
[3]. Dietary polyphehols have been shown to inhibit LDL oxidation, scavenge 36 
superoxide and other ROS and increase plasma antioxidant capacity [4]. Furthermore, 37 
some dietary phenolic compounds, mainly polyphenols, have been shown to affect 38 
human platelet function in vitro and in vivo [5, 6]. Platelets play a central role in the 39 
formation of plaques within blood vessels, contributing to early inflammatory events 40 
[5], so, the observed cardiovascular benefits attributed to olive oil may be linked to the 41 
anti-platelet activity of olive oil polyphenols and thus to the suppression of platelet 42 
activation. 43 
The ability of many flavonoids and phenols to inhibit peroxidation of hepatic 44 
microsomal preparations from vitamin E deficient rats might indicate that these dietary 45 
compounds could have significant “vitamin E-like” antioxidant activity in biological 46 
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systems [7]. The ability of dietary antioxidants to impair free radical-mediated oxidation 47 
of proteins, lipids and DNA, which are implicated in the pathogenesis of many chronic 48 
diseases [8], are believed to beneficially affect health. 49 
After olive oil extraction, only a low percentage of the total phenolic compounds 50 
present in the olive fruits are found in the virgin olive oil. The remaining phenolics (98-51 
99 %) end up in alperujo, a by-product from the modern two-phase processing 52 
technique used in the olive oil production [9].  53 
Nowadays the olive oil industry is starting to generate new by-products richer in 54 
phenols by thermal process applications like hydroxytyrosol (HT), 3,4-55 
dihydroxyphenylglycol (DHPG), hydroxytyrosol acetate (HTA) or polymeric phenolic 56 
fractions (PPF) [10]. The industrial use of a patented steam treatment (ST) [11] allows 57 
the formation of liquid source that enables the extraction and the isolation of the most 58 
important phenols present in virgin olive oil. The ST leads to obtain a natural liquid 59 
source without suspended solid that is richer in phenols than the other liquid sources 60 
obtained from olive oil wastes. This treatment was designed in base of the effects found 61 
in the “Steam Explosion” system (SE) in which high temperatures and pressures (up to 62 
240 ºC and 40 kg/cm2) are needed for a few minutes followed by an explosive 63 
depressuration. The new ST operates at lower temperatures up to 170 ºC and retention 64 
time of one hour, avoiding the explosion and then, the technical complications; hence its 65 
scale up has been successfully done.  66 
In previous work [6] the anti-platelet effects of alperujo extract obtained after an 67 
SE treatment was measured comparing with the effect of simple phenols like 68 
hydroxytyrosol and 3,4-dihydroxyphenylglycol (DHPG), detecting by the first time the 69 
synergic effect of these two simple phenols. The effects on animal model of the alperujo 70 
extract treated by SE have been also studied [12]. Because the thermal conditions and 71 
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the concentration of phenols of both treatments are different, together with the industrial 72 
use of the ST, the study of the in vitro activities of the phenols obtained from alperujo 73 
treated by ST are necessary. In the present work, the phenolic extract obtained from the 74 
alperujo treated industrially by ST has been tested, for the first time, to assess in vitro 75 
their anti-platelet in human platelet screening tool and their antioxidant effects in animal 76 
microsomes model.  77 
 78 
2. Materials and Methods 79 
 80 
2.1 Test compounds 81 
Phenolic extracts (PE) were obtained from ST of alperujo at 160ºC for 60 min 82 
[10]. Polymeric phenolic fractions (PPF) were isolated from the phenolic extracts by 83 
chromatography fractionation using Amberlite® XAD [13]. Hydroxytyrosol (HT) and 84 
3,4-dihydroxyphenylglycol (DHPG) were purified by an ionic resin column following 85 
the process described by Fernández-Bolaños et al., (2002)[14] and Fernández-Bolaños 86 
et al., (2008)[15], respectively. Hydroxytyrosol acetate (HTA) was isolated by an ionic 87 
resin column following the process described by Rodríguez-Gutiérrez et al., (2011)[16]. 88 
Figure 1 shows the HPLC-profile of each of the test compounds used. 89 
 90 
2.2. Determination of the total phenolic content 91 
To complete the simple analysis of phenols the total phenolic content of the test 92 
compounds was measured according to the Folin−Ciocalteu method [17] and expressed 93 
as grams of gallic acid equivalents per kilogram of extract. 94 
 95 
2.3. HPLC-DAD. 96 
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The different phenols were quantified using a Hewlett-Packard 1100 liquid 97 
chromatography system with a C-18 column (Teknokroma Tracer Extrasil ODS-2, 250 98 
mm × 4,6 mm i.d., 5 μm). The system was equipped with a diode array detector (DAD; 99 
the wavelengths used for quantification were 254, 280, and 340 nm) and Rheodyne 100 
injection valves (20 μL loop). The mobile phases were 0.01% trichloroacetic acid in 101 
water and acetonitrile utilizing the following gradient over a total run time of 55 min: 102 
95% A initially, 75% A at 30 min, 50% A at 45 min, 0% A at 47 min, 75% A at 50 min, 103 
and 95% A at 52 min until the run was completed. Quantification was carried out by 104 
integration of peaks at different wavelengths with reference to calibrations made using 105 
external standards. The linearity of standards curve was expressed in terms of the 106 
determination coefficients plots of the integrated peaks area versus concentration of the 107 
same standard. These equations were obtained over a wide concentration range in 108 
accordance with the levels of these compounds in the samples. The system was linear in 109 
all cases (r > 0.99). Three replicates were carried out on the same day. 110 
 111 
2.4. Measurement of platelet aggregation 112 
 113 
Blood sampling procedure 114 
Blood samples were obtained from 23 healthy volunteers from European countries 115 
(9 males and 14 females and 25-60 years of age). Each volunteer signed consent form 116 
before donating blood. Volunteers had abstained from anti-inflammatory drugs and food 117 
supplements for at least two weeks prior to blood sampling and had a normal blood cell 118 
count. Blood was obtained using siliconized 21 gauge butterfly needles into 10 mL S-119 
Monovette blood collection tubes containing 1 mL trisodium citrate as anticoagulant 120 
(Sarstedt Ltd, Beaumont Leys, UK).  121 
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 122 
In vitro platelet aggregation 123 
Agonist-induced platelet aggregation was measured in platelet rich plasma (PRP) 124 
upon incubation with the test compounds using a PACKS 4 machine (platelet 125 
aggregation chromogenic kinetic system) as described by us previously [6, 18]. Briefly, 126 
blood from healthy volunteers was collected into sodium citrate 3.8% (9:1 v/v) and the 127 
PRP was obtained according to standardized procedures. The plasma poor in platelets 128 
(PPP) was used to adjust the PRP to a platelet count of 300±20 platelets /µL using the 129 
sysmex haematology analyser (KX-21N, sysmex, Germany). Once adjusted, the PRP 130 
was left to rest at 37°C. PRP was incubated at least ten times with different platelets 131 
with 100 and 500 mg/L of PE; 10, 50 and 100 mg/L of HTA; 10, 50 and 100 mg/L of 132 
PPF; 8+0.6, 43+3, 85+6 mg/L HTA + HT respectively; or PBS as a control, for 10 133 
minutes at 37 ºC. To induce the platelet aggregation, collagen (final concentration 3 and 134 
5 µg/mL) or thrombin receptor analogue peptide (TRAP) (final concentration 25µM) 135 
were added. The platelet aggregation measurement was started 90 minutes after blood 136 
sampling. After 10 minutes, the curve of platelets aggregation was obtained, and platelet 137 
aggregation was expressed as percentage of maximal aggregation. 138 
 139 
2.5. Inhibition of lipid peroxidation in vitamin E-deficient microsomes. 140 
Microsomal lipid peroxidation was assessed by measuring the reaction of 141 
malonadehyde, a product of lipid oxidation, with thiobarbituric acid to produce 142 
thiobarbituric acid reactive substances (TBARS). These are quantified by high pressure 143 
liquid chromatography (HPLC). Each extract were tested in triplicate. 144 
For this study, liver microsomes from vitamin E-deficient male weanling rats of 145 
the Rowett Hooded Lister strain were used, as described by us previously [12]. Briefly, 146 
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rats that had been on a diet containing less than 0.5 mg/kg vitamin E (-VE) for 13 weeks 147 
were anesthetized with ether and bled by cardiac puncture prior to removal of the liver. 148 
This protocol was approved by the Ethical Review Committee of Animal Studies at the 149 
Rowett Research Institute, and was conducted in compliance with the Animals 150 
(Scientific Procedures) Act, 1986. 151 
Microsomes were extracted from homogenised liver samples by washing with 152 
0.154 M KCl and suspension in potassium phosphate buffer 0.05 M pH 7.4. The protein 153 
concentration was determined by the Biuret method and adjusted to 10 mg/mL with 154 
0.05 M potassium phosphate buffer pH 7.4. Vitamin E deficiency in rats was confirmed 155 
by plasma, tissue and microsomal vitamin E concentrations, which were below the limit 156 
of detection by HPLC. The effect of the test compounds on in vitro microsomal lipid 157 
peroxidation in the microsomes was determined as described by the method of Duthie et 158 
al., (1991)[19]. Briefly, ethanol solutions (20 µL) with the test compounds in a 159 
concentration 25 times higher than required were incubated with microsomal 160 
preparations (0.5 mL) for 30 min at room temperature. Solutions with α-tocopherol 161 
were used as a control. For the control sample deficient in α-tocopherol, only 20 µL of 162 
EtOH was added. 0.1 mL of microsome solution with compounds was mixed with 0.5 163 
mL of 0.05mM ascorbic acid, 1 mL of a 2mMADP /6µM Fe2+ solution and 3.4 mL of 164 
0.05M phosphate buffer pH 7.4. The mixture was incubated at 30 ºC and different 165 
aliquots were taken at 0, 5, 10 and 20 min for determination of thiobarbituric acid-166 
reactive substances (TBARS) by HPLC. To this 1mL of 0.67% thiobarbituric 167 
acid:acetic acid (1:1) and 2 mL of water were added and the solution was heated for  30 168 
min at 100 ºC in order to let the colour develop (measured at 535 nm).  169 
The amount of generated TBARS was quantified by HPLC (Allience) equipped 170 
with a bomb (Waters 2695) and a fluorescence detector (Waters 2475). The column 171 
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used were Phenomenex Luna 5u C18 (2) 100 A, 150 x 4.60 mm, the mobile phase was 172 
60 % of KH2PO4 50 mM pH 7.0 and 40% of MeOH at a flow of 0.8 mL/min for 12 173 
minutes, in isocratic mode. Inhibition of lipid peroxidation was calculated as follows:  174 
100·
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 176 
where AUC (-VE) = area under curve in microsomes from rats deficient in vitamin E 177 
and AUC (-VE + Comp) = area under curve in microsomes from rats deficient in 178 
vitamin E plus test compound. The ability to inhibit microsomal lipid peroxidation by 179 
each extract or compound (mixture) was compared with a negative control (no 180 
incubation) and two positive controls (effect in microsomes from rats with adequate diet 181 
of vitamin E (on a vitamin E-adequate diet 100 mg dα-tocopherol/kg) and effect in 182 
microsomes from rats on a vitamin E-deficient diet supplemented with 100 mg/kg diet 183 
of dα-tocopherol.  184 
 185 
2.6. Statistical analysis 186 
STATGRAPHICS ® plus software was used for statistical analysis. Comparisons 187 
amongst samples were made using one-way analysis of variance (ANOVA) and 188 
the Least Significant Difference (LSD) method. A p-value less than 0.05 was 189 
considered significant. 190 
 191 
3. Results  192 
 193 
3.1 Inhibition of platelet aggregation  194 
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In this study, the anti-platelet properties of two natural extracts (PE and PPF) and 195 
a purified compound (HTA) obtained from a new industrial source have been screened. 196 
Furthermore, the potential synergic effects between hydroxytytosol acetate and 197 
hydroxytyrosol (HTA+HT) have been also studied by the first time.  198 
The characteristics of the volunteers from which we obtained blood samples are 199 
shown in Table 1. Incubation of platelet-rich plasma from healthy volunteers with 100 200 
mg/L of hydroxytyrosol acetate, which equates to approximately 510 µM, resulted in a 201 
significant (p< 0.05) inhibition of 3 and 5 µg/L collagen- and 25 µM TRAP- induced 202 
platelet aggregation by 38, 27 and 37%, respectively (Figure 2). Incubation with 50 203 
mg/L HTA also resulted in a significant inhibition of 5 µg/L collagen and 25 µM 204 
TRAP-induced platelet aggregation by 7 and 22%, respectively (Figure 2).  205 
In this study, two natural phenolic extracts, obtained from alperujo hydrothermally 206 
treated at 160 ºC/60 min (PE) and a polymeric phenolic fraction (PPF) isolated from 207 
phenolic extract have been also screened. The activity of this new phenolic polymeric 208 
fraction (PPF) isolated and characterized has been tested for first time. This PPF was 209 
composed mainly of phenolic compounds with small amounts of carbohydrates, 210 
proteins and ash, and it was formed during ethyl acetate extraction process from the 211 
autohydrolysis liquids of steam-treated alperujo [13]. Incubation with 100 mg/L PPF 212 
resulted in significant (p<0.05) inhibition of 3 and 5 µg/L collagen and 25µM TRAP-213 
induced platelet aggregation by 23, 13 and 22%, respectively. For the assays with PE a 214 
concentration of 240 g phenols/kg extract has been found by the Folin-Calteciau 215 
method. The HPLC results suggested that 1 gram of phenolic extract contained 109.3 216 
mg HT, 10.3 mg PPF, 9.9 mg DHFG and 8.5 mg HTA. Only the highest test 217 
concentration of PE (i.e. 500 mg/L) significantly inhibited 3 and 5 µg/L collagen and 25 218 
µM TRAP-induced platelet aggregation by 52, 40 and 19%, respectively (Figure 2).  219 
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 220 
3.2. Inhibition of microsomal lipoxidation from vitamin E deficient rats. 221 
The antioxidant properties of two natural extracts (PE and the PPF) and three 222 
purified compounds (HT, HTA and DHPG) have been screened. Furthermore, two 223 
mixtures of compounds (HT + DHPG) and (HTA + HT) were evaluated. Previous 224 
studied showed that decrease in membrane concentration of α-tocopherol increased the 225 
rates of TBARS formation in all tissues, but the effect was especially pronounced in 226 
adrenal mitochondrial and microsomes [20]. 227 
The phenolic extract (PE), HTA and the HT+DHPG mixture showed most 228 
inhibition of lipid oxidation inhibition at the lowest test concentrations (Tables 2 and 3). 229 
0.05 mM of HTA inhibited lipid peroxidation by 20.8% (Table 3). Interestingly this was 230 
very similar to the highest concentration (0.4 mM) but much more effective than the 231 
intermediate concentration (13.5% of inhibition). HT and DHPG decreased lipid 232 
peroxidation of the microsomal preparation from vitamin E deficient rats in a time-233 
dependent manner, and the protection against peroxidation improved with increasing 234 
concentrations (Figure 3).  235 
 236 
4. Discussion 237 
4.1 Inhibition of platelet aggregation  238 
The anti-platelet property of the HTA and HT mixture was more effective than of 239 
each component separately. So when HT was tested alone 6 mg/L of compound 240 
inhibited platelet aggregation by 4 % using collagen-induced platelet aggregation and 241 
any effect inhibitory was observed for 3 mg/L. Indeed, incubation with 43+3 mg/L 242 
(219+19.5 µM) HTA and HT resulted in a significant (p<0.05) inhibition of 3 and 5 243 
µg/L collagen and 25 µM TRAP-induced platelet aggregation by 30, 22 and 31%, 244 
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respectively (Figure 2). A similar effect was observed for 85+6 mg/L HTA + HT 245 
(433+30.6 µM), inhibiting platelet aggregation by 85, 71 and 50%, respectively (Figure 246 
2). González-Correa, et al., (2009)[21] observed that 26 and 48 µM HTA inhibited 247 
collagen-induced platelet aggregation by 50%. This antiplatelet effect was stronger than 248 
that of HT, and similar to that of acetylsalicylic acid (ASA), Hubbard, et al., (2003)[22] 249 
considered different simple phenols and found that for p-coumaric, caffeic, ferulic and 250 
sinapic acid a concentration of 478-816 µM was necessary to inhibit collagen-induced 251 
platelet aggregation by 50%. Furthermore, concentrations between 10 and 100 µM of 252 
gallic acid inhibited TRAP-induced platelet aggregation by 10-50 % [23]. Ostertag et al. 253 
2011 [18] found that 100 µM of cathecol, resorcinol, pyrogallol and hippuric acid 254 
inhibited in vitro collagen-induced platelet aggregation. A previous study in our group 255 
using the same samples [6] showed that 40 mg/L of HT inhibited collagen-induced 256 
platelet aggregation by 5%, whereas a mixture of HT and DHPG (40+5 mg/L 257 
respectively) inhibited collagen-induced platelet aggregation by approximately 12 % in 258 
a synergistic manner. In most of these studies, only relatively high concentrations of 259 
phenolic compounds caused significant anti-platelet effects in an in vitro screening 260 
model. Although these models can effectively measure the potential pharmacological 261 
anti-platelet effects of a large range of bioactive compounds, the effective 262 
concentrations may not necessarily be physiologically relevant from a dietary 263 
perspective [6].  264 
With regard to the phenolic extract, in a previous study [6] using an PE obtained 265 
by SE, a similar concentration of 500 mg/L alperujo extract significantly inhibited 266 
collagen- and TRAP-induced platelet aggregation by 25 and 16%, respectively. The 267 
higher efficacy of PE in the current study could be due to a different phenol 268 
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composition because the lower severity used to treat the alperujo by the industrial ST 269 
system.  270 
 271 
4.2. Inhibition of microsomal lipoxidation from vitamin E deficient rats. 272 
The HT+DHPG mixture produced a higher percentage inhibition (31%) for lower 273 
test concentrations (0.25 mM+0.25mM), which was more powerful than the efficacy of 274 
individual compounds (Table 2). Also increasing concentrations of PPF showed 275 
improved inhibition of lipid peroxidation, up to 58 % inhibition for the highest 276 
concentration (200 mg / L) (Table 3). The high efficacy of PE to act as an antioxidant 277 
may be explained by the fact that the extract contains different compounds that work in 278 
a synergistic fashion to inhibition lipid peroxidation, or it contains individual minor 279 
components that have high capacity of inhibition of lipid peroxidation 280 
In a detailed study, Duthie & Morrice, (2012)[7] found that different flavonoids 281 
(i.e. quercetin, kaempferol, myricetin, galingin and fisetin) inhibited lipid peroxidation 282 
by 68-88%, a similar range than the olive phenols studied in microsomes derived from 283 
livers of rats deficient in vitamin E. Mitchell, et al., (1998)[24] observed similar results 284 
for kaempherol, which of all phytoestrogens had the greatest ability to inhibit lipid 285 
peroxidation in vitamin E-deficient microsomes with an IC50 of 160 µM. In 286 
comparison, IC50 concentrations required to inhibit lipid peroxidation in liver 287 
microsomes was 31 µM for α-tocopherol, and 124 µM for quercetin. The IC50 values 288 
for the isoflavones, chalcones and coumestan were approximately 35, 22 and 16-fold 289 
higher than that of α-tocopherol, respectively. 290 
 291 
5. Conclusion 292 
 293 
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The results of this study show that the olive extracts obtained from a new 294 
industrial liquid source produced by ST application to alperujo have higher activities 295 
that the PE previously reported using the SE as a treatment. Beside, a synergist effect of 296 
HTA and HT has been found by the first time. The PE and the isolated phenols obtained 297 
may protect against platelet activation, platelet adhesion and have anti-oxidant 298 
properties. The extraction of these compounds can be accomplished in a sustainable 299 
manner through effective use of the industrial source from the olive oil by-product 300 
manufacturing process, offering a unique opportunity to produce functional ingredients 301 
that alone, or in effective combinations, could be added to foods to enhance their health 302 
properties.  303 
 304 
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Figure caption. 405 
 406 
Figure 1: HPLC-profile of different samples used in this work. 407 
 408 
Figure 2: Inhibition of platelet aggregation by HTA, HTA+HT, PPF and PE using 3 409 
µg/L collagen (A), 5 µg/L collagen (B) or 25 µM TRAP (C) as an agonist. Platelet 410 
inhibition is expressed as the % decrease in the areas under the curve for platelet 411 
aggregation measured by light-transmission aggregometry when compared with control 412 
(PBS). * Significantly different from control (p >0.05); (-) mean value. 413 
 414 
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Figure 3: Pre-incubation of hepatic microsomal preparations from vitamin E deficient 415 
rats with a HT and DHPG on production of thiobarbituric reactive substances (TBARS) 416 
following initiation of peroxidation with Fe/ADP: 417 
 418 
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